seed
Stage
About
DISCO Pharmaceuticals develops a platform for surfaceome mapping to identify cell-surface protein targets, enabling the discovery of targeted cancer therapies focused initially on small cell lung cancer and microsatellite-stable colorectal cancer.
Explore DISCO Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.